Filing Details

Accession Number:
0001493152-23-038573
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-10-27 20:00:08
Reporting Period:
2023-10-27
Accepted Time:
2023-10-27 20:00:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1106838 Sonnet Biotherapeutics Holdings Inc. SONN Pharmaceutical Preparations (2834) 522102141
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1664386 Pankaj Mohan 100 Overlook Center,
Suite 102
Princeton, NJ 08540
Chairman, President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-10-27 34,375 $0.00 59,526 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant to Purchase Common Stock Acquisiton 2023-10-27 68,750 $0.00 68,750 $1.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
68,750 2023-10-27 2028-10-27 No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 25 Indirect By Child
Common Stock 3,021 Indirect By Mohan Family Office
Footnotes
  1. Reporting Person purchased 34,375 shares of common stock and 68,750 warrants to purchase 68,750 shares of common stock pursuant to an underwritten public offering by the Issuer at $1.60 per share and accompanying two warrants. The offering closed on October 27, 2023.
  2. Includes unvested restricted stock units.
  3. All amounts reflect the 1:22 reverse stock split effective as of August 31, 2023.
  4. Reporting Person jointly exercises dispositive and voting power over the securities owned by the Mohan Family Office.